Liothyronine Sodium Bp Mercury Pharma Group

Liothyronine Sodium, the active ingredient in Liothyronine Sodium Bp Mercury Pharma Group, is a thyroid hormone presented as an oral dosage form for oral use. It is employed to treat hypothyroidism, myxedema coma, and other conditions requiring thyroid hormone replacement in adults and children.

GNH USA supplies Liothyronine Sodium Bp Mercury Pharma Group as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Liothyronine sodium is a synthetic thyroid hormone that acts on the hypothalamic‑pituitary‑thyroid axis to restore normal metabolic function. - Hypothyroidism: normalizes circulating thyroid hormone levels, alleviating fatigue, weight gain, and cold intolerance in patients with underactive thyroid. - Myxedema coma: provides rapid T3 supplementation to support cardiovascular and respiratory function in life‑threatening severe hypothyroidism. - Thyroid hormone replacement therapy: maintains euthyroid status in individuals who have had thyroidectomy or radioactive iodine ablation.

Liothyronine sodium may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Palpitations: sensation of rapid or irregular heartbeat. - Anxiety: heightened nervousness or restlessness. - Headache: mild to moderate cranial pain. - Nausea: mild stomach upset. - Diarrhea: loose stools.

Serious or Rare Side Effects: - Cardiac arrhythmias: potentially life‑threatening irregular heart rhythms. - Myocardial infarction: increased risk of heart attack in susceptible patients. - Severe hyperthyroidism: fever, tremor, and marked weight loss. - Severe bone loss: increased risk of osteoporosis with long‑term use. - Allergic reactions: rash, itching, swelling, or anaphylaxis.

When prescribing liothyronine sodium, clinicians should consider several safety precautions to minimize risks. - Cardiac disease: adjust dose and monitor heart function in patients with coronary artery disease. - Elderly patients: start with lower dose and titrate cautiously due to increased sensitivity. - Adrenal insufficiency: ensure adequate glucocorticoid replacement before initiating therapy. - Pregnancy and lactation: evaluate risk‑benefit ratio; use only if clearly needed. - Drug monitoring: regularly assess thyroid function tests to avoid over‑replacement. - Store at room temperature: keep in original container, protect from moisture and light.

Liothyronine sodium can interact with several medicines, altering its effectiveness or increasing toxicity.

Major Interactions (Avoid): - Antithyroid drugs (e.g., propylthiouracil, methimazole): block thyroid hormone synthesis and negate therapeutic effect. - Anticoagulants (warfarin): enhanced anticoagulant effect may increase bleeding risk. - Digoxin: increased serum digoxin levels can lead to toxicity.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask tachycardia and other hyperthyroid signs, requiring careful monitoring. - Oral contraceptives: estrogen may raise thyroid‑binding globulin, affecting hormone levels. - Statins: potential for altered metabolism; monitor lipid profile and thyroid function.